Skip to main content
. 2019 Jun 2;125(16):2772–2781. doi: 10.1002/cncr.32079

Figure 1.

Figure 1

Clinical outcome in patients with high‐grade serous ovarian carcinomas (HGSOCs) demonstrating high EMSY expression. (A) Overall survival (OS) in the Edinburgh cohort. (B) Progression‐free survival (PFS) in the Edinburgh cohort. (C) OS in the Medical Research Council (MRC) ICON7 clinical trial cohort. (D) OS in the MRC ICON7 clinical trial cohort stratified by trial arm. multiHR indicates multivariable hazard ratio; uniHR, univariable hazard ratio.